SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-011645
Filing Date
2024-04-10
Accepted
2024-04-10 16:36:40
Documents
14
Period of Report
2024-04-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20240408_8k.htm   iXBRL 8-K 21536
  Complete submission text file 0001437749-24-011645.txt   149204

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240405.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240405_def.xml EX-101.DEF 11029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240405_lab.xml EX-101.LAB 14742
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240405_pre.xml EX-101.PRE 11134
18 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240408_8k_htm.xml XML 2731
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 24836248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)